Barchart on MSN

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up

The profit-sharing continues, but the commercial tide has shifted, and Pfizer is now chasing a different growth engine. Its $10 billion acquisition of Metsera, clinched after a bidding war, signals a ...
The Pharma Letter

Pfizer scores a win for mRNA vaccines with influenza data

US pharma giant Pfizer has provided a reminder of the merits of mRNA-based vaccines as health leaders in the USA continue to question their safety.
ABC7 San Francisco

Pfizer price: COVID-19 vaccine list price could be $130 per dose once government contracts end

Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose. This price model comes down to ...
Morningstar

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Phase 3 clinical trial cohort of adults 65+ and 18-64 with at least one underlying risk condition shows at least a 4-fold increase in LP.8.1-neutralizing antibody titers after receiving the ...
The Pharma Letter

MHRA broadens Pfizer Abrysvo licence to include RSV disease prevention

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pfizer’s extension to the licence of the ...